Moody’s assigns ‘Aa2’ rating to Mayo Clinic’s bonds

Moody’s Investors Service has assigned an “Aa2” rating to Rochester, Minn.-based Mayo Clinic’s proposed $290 million of series 2016B bonds.

Advertisement

The rating assignment is based on several factors, including Mayo’s size as well as its demonstrated national and international draw for patients.

The outlook is stable, reflecting Moody’s Investors Service’s expectation that Mayo is positioned to generate adequate adjusted operating margins and sustain liquidity ratios.

More articles on healthcare finance:
Louisiana hospitals on brink of bankruptcy as battle between owner, operator escalates
FAIR Health database adds Connecticut mobile app
Northwell Health’s finances steady despite insurance division losses

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.